News

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...
New drug shows impressive results against lipoprotein(a), a genetic form of cholesterol that affects millions but remains ...
About a quarter of people risk heart attacks and strokes because they inherited a kind of cholesterol that statin drugs can’t treat.
Lepodisiran, a new drug, slashed levels of “stealthy cholesterol”—a hidden heart risk affecting 1 in 5 people—by up to 95% in ...
High levels of a chemical that is believed to be behind sudden and inexplicable heart attacks and strokes could soon have multiple drugs to treat it ...
Deciding whether to start hormone therapy during the menopause transition, the life phase that's the bookend to puberty and ...
Visit-to-visit variability in lipid levels is associated with an increased risk for heart failure in patients with T2D, ...
The Phase II study found that lepodisiran significantly reduced levels of genetically inherited cardiovascular risk factor.
CHICAGO, IL—An investigational agent given by subcutaneous injection can drastically reduce levels of lipoprotein (a), with ...
Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting ...